直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Seminar

US & EU Licensing

June 4-5, 2019

Hiedelberg, Germany

FORUM Institut für Management GmbH

Finnegan partners Brian Kacedon, Kathleen Daley, and Tim May will lead a FORUM Institut for Management’s seminar considering principal differences between US and EU license agreements, license agreement drafting, international licenses, unpatented technology agreements, implied licenses, and avoiding antitrust and misuse issues. The program will take place at the Europäischer Hof Heidelberg hotel in Hiedelberg, Germany. For more information, or to register, please see FORUM Institut for Management’s website.

Related Practices

Licensing, Pooling, and Other Transactions

Prosecution and Portfolio Management

Related Professionals

Timothy J. May
Partner
Washington, DC
+1 202 408 4447
Email
Kathleen A. Daley
Partner
Washington, DC
+1 202 408 4098
Email
D. Brian Kacedon
Partner
Washington, DC
+1 202 408 4301
Email

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP